Skip to main content
. 2005 Nov 11;61(1):10–16. doi: 10.1136/thx.2004.034181

Table 1 Baseline characteristics of participants with and without obstructive lung disease (OLD).

Variable With OLD (n = 268) Without OLD (n = 2005) p value
Demographic characteristics
 Age 73.6 (2.8) 73.2 (2.8) 0.03
 Sex (% male) 58 50 0.02
 Race (% black) 56 62 0.03
 Site (% Memphis) 51 49 0.4
Co‐morbid conditions
 Hypertension (%) 47 50 0.3
 Diabetes (%) 14 15 0.4
 History of CHF (%) 0.8 1.2 0.8
 History of COPD (%) 41.8 10.6 <0.0001
 Current smoking (%) 32 9 <0.0001
 Past smoking (%) 54 46
 Pack years of smoking‡ 39 (9–57) 2 (0–25) <0.0001
 Depression (%) 11.4 12.5 0.6
Pulmonary function
 FEV1 (% predicted) 65.1 (16.6) 98.6 (18.2) <0.0001
  Mild ⩾70% predicted (%) 35 100
  Moderate 51–70% predicted (%) 38 0
  Severe <50% predicted (%) 27 0
Body composition
 Body mass index (kg/m2) 25.4 (4.7) 27.4 (4.7) 0.001
 Visceral adiposity (cm2) 149.4 (77) 146.9 (67) 0.4
 Lean body mass (kg) 47 (10) 48 (10 ) 0.008
 Weight (kg) 72 (14) 76 (15) <0.0001
Muscle strength and muscle mass
 Grip strength (kg) 34.1 (8) 32.5 (7) 0.3
 Knee extensor strength (Nm) 102.5 (39) 108.9 (38) 0.017
 Thigh muscle area by CT scan (cm2) 102 (39) 108 (39) 0.002
 Lower limb lean mass by DXA (kg) 7.4 (1.7) 7.6 (1.8) 0.04
 Knee extensor strength/thigh muscle area by CT scan (Nm/cm2) 0.95 (0.24) 0.95 (0.22) 0.9
 Maximal inspiratory pressure (cm H2O) 64.7 (30) 74.2 (32) <0.0001
Inflammatory markers†
 TNF (pg/ml) 3.4 (1.7) 3.4 (1.5) 0.3
 IL‐6 (pg/ml) 2.6 (1.9) 2.2 (1.8) <0.0001
 CRP (mg/l) 3.5 (5.3) 2.5 (3.7) <0.0001
Medications
 Steroids (%) 4.5 1.2 0.006

CHF, congestive heart failure; FEV1, forced expiratory volume in 1 second; CRP, C‐reactive protein; IL, interleukin; TNF, tumour necrosis factor.

Data expressed as mean (SD) unless specified otherwise.

†Data log converted since distribution not normal.

‡Median with interquartile range.